University of Michigan researchers have overturned a decades-old assumption about how pancreatic cancer develops, discovering that precancerous lesions in the pancreas maintain a normal cellular environment rather than the corrupted one scientists expected. The finding, published in Cancer Discovery, suggests that the transformation from precancerous to malignant is far more conditional than previously understood—and potentially more preventable.
For years, cancer researchers have known that tumors don't exist in isolation. Instead, cancer cells manipulate surrounding healthy cells into becoming "helpers," creating a supportive ecosystem called the microenvironment that feeds tumor growth. Scientists studying pancreatic intraepithelial neoplasia, or PanIN—early lesions that can precede pancreatic cancer—assumed these precancerous cells would be doing the same thing: gradually corrupting their neighborhood. The precursor lesions even express many of the same genes as cancer cells, though less strongly. So the prediction seemed logical: if the cancer cells were already expressing tumor-like genes, surely they'd already be recruiting accomplices in their cellular surroundings.
The research team, led by Marina Pasca di Magliano, Ph.D., the Maud T. Lane Professor of Surgical Immunology at University of Michigan, found something entirely different. "The microenvironment of these precursor lesions is the same as the microenvironment of the normal pancreas," Pasca di Magliano said. "The lesions have not convinced any of the cells around them to change. That's not what we were expecting."
This unexpected discovery was made possible through an unusual partnership between the U-M Rogel Cancer Center and Gift of Life Michigan, which gave researchers access to healthy donor pancreases—a rare resource in cancer research. The team isolated precancerous lesions from more than 150 donated pancreases from donors aged 20 to 70. Using cutting-edge technologies including single cell RNA sequencing and spatial transcriptomics, they mapped the genetic expression of individual cells and specific tissue sections with unprecedented precision. As co-senior author Timothy Frankel, M.D., the Maud T. Lane Professor of Surgical Oncology at U-M, explained, the new techniques allowed them to focus on the lesions themselves rather than the surrounding tissue, dramatically improving their ability to understand what was actually happening at the cellular level.
The implications are profound. This finding helps explain why precancerous pancreatic lesions are surprisingly common—researchers have found them in people as young as 20—while pancreatic cancer remains relatively rare. If precancerous lesions aren't already corrupting their surroundings, something else must trigger their transformation into cancer: inflammation, pancreatitis, smoking, age, obesity, or other accumulated stressors.
That realization opens a new therapeutic window. If researchers can identify what factors cause the microenvironment to shift, supporting the lesions' transformation, they might be able to target and intercept that process before malignancy develops. The goal is no longer to reverse an already-corrupted system, but to prevent the corruption from happening in the first place. Understanding these triggers could ultimately allow doctors to identify which patients with precancerous lesions are at genuine risk and potentially intervene to stop cancer before it starts.